Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results
1999; Elsevier BV; Volume: 10; Issue: 4 Linguagem: Inglês
10.1023/a
ISSN1569-8041
AutoresFrankie A. Holmes, Vicente Valero, R S Walters, R. Theriault, Daniel J. Booser, Harry Gibbs, Giuseppe Fraschini, A. U. Buzdar, Jie Willey, D. Frye, Lina Asmar, G. N. Hortobágyi,
Tópico(s)Chemotherapy-related skin toxicity
Referência(s)